Strength

規(guī)格

200 mg  50mg

Product   License

PL 43801/0036 - 0001

PL 43801/0037   - 0001

Indications

適應(yīng)癥

? Invasive   aspergillosis.

? Candidaemia   in non-neutropenic patients.

? Serious   invasive Candida sp. infections when the fungus is resistant to fluconazole.

? Serious   fungal infections caused by Scedosporium sp. or Fusarium sp.

Voriconazole   film-coated tablet is intended for patients with worsening, possibly   life-threatening, fungal infections.

?侵襲性曲霉菌病。

?非中性粒細(xì)胞減少患者的念珠菌血癥。

?嚴(yán)重侵襲性念珠菌感染，當(dāng)真菌對氟康唑有耐藥性時。

?由Scedosporium   sp.或Fusarium sp.引起的嚴(yán)重真菌感染。

Approved Date

批準(zhǔn)日期

07/10/2016

Market Authorization   Holder

持有人

SCIECURE   PHARMA LIMITED

Manufacture

生產(chǎn)商

Beijing   Sciecure Pharmaceutical Co., Ltd.

北京世橋生物制藥有限公司